Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85,955Revenue $M22,859Net Margin (%)22.5Altman Z-Score1.9
Enterprise Value $M108,825EPS $3.1Operating Margin %33.0Piotroski F-Score5
P/E(ttm)30.9Beneish M-Score-2.1Pre-tax Margin (%)29.1Higher ROA y-yN
Price/Book17.710-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %--Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow19.3y-y EBITDA Growth Rate %-16.8ROA % (ttm)16.1Higher Current Ratio y-yN
Dividend Yield %4.0PEG--ROE % (ttm)170Less Shares Outstanding y-yN
Payout Ratio %112Shares Outstanding M1,635ROIC % (ttm)41.2Gross Margin Increase y-yY

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABBVNWQ Managers 2015-12-31 Reduce-0.65%$48.27 - $64.13
($57.69)
$ 52.58-9%Reduce -50.59%754,413
ABBVFirst Eagle Investment 2015-12-31 Sold Out -0.14%$48.27 - $64.13
($57.69)
$ 52.58-9%Sold Out0
ABBVDavid Dreman 2015-12-31 Reduce-0.03%$48.27 - $64.13
($57.69)
$ 52.58-9%Reduce -15.80%26,267
ABBVMario Gabelli 2015-12-31 Reduce$48.27 - $64.13
($57.69)
$ 52.58-9%Reduce -7.58%40,600
ABBVKen Fisher 2015-12-31 Add$48.27 - $64.13
($57.64)
$ 52.58-9%Add 0.77%935,104
ABBVFirst Eagle Investment 2015-09-30 Add0.05%$52.5 - $71.23
($65.09)
$ 52.58-19%Add 55.71%1,056,150
ABBVDavid Dreman 2015-09-30 Add0.02%$52.5 - $71.23
($65.09)
$ 52.58-19%Add 10.27%31,197
ABBVJoel Greenblatt 2015-09-30 Add0.02%$52.5 - $71.23
($65.09)
$ 52.58-19%Add 117.34%73,037
ABBVKen Fisher 2015-09-30 Reduce-0.01%$52.5 - $71.23
($65.09)
$ 52.58-19%Reduce -7.82%927,959
ABBVDodge & Cox 2015-09-30 Reduce$52.5 - $71.23
($65.09)
$ 52.58-19%Reduce -2.92%33,255
ABBVNWQ Managers 2015-09-30 Reduce$52.5 - $71.23
($65.09)
$ 52.58-19%Reduce -3.59%1,526,806
ABBVMario Gabelli 2015-09-30 Reduce$52.5 - $71.23
($65.09)
$ 52.58-19%Reduce -5.65%43,930
ABBVJoel Greenblatt 2015-06-30 Reduce-0.23%$57.01 - $70.46
($65.18)
$ 52.58-19%Reduce -93.95%33,605
ABBVNWQ Managers 2015-06-30 Reduce-0.19%$57.01 - $70.46
($65.18)
$ 52.58-19%Reduce -13.88%1,583,682
ABBVDavid Dreman 2015-06-30 Add0.11%$57.01 - $70.46
($65.18)
$ 52.58-19%Add 193.03%28,292
ABBVFirst Eagle Investment 2015-06-30 Buy 0.11%$57.01 - $70.46
($65.18)
$ 52.58-19%New holding678,300
ABBVKen Fisher 2015-06-30 Reduce$57.01 - $70.46
($65.18)
$ 52.58-19%Reduce -0.40%1,006,679
ABBVMario Gabelli 2015-06-30 Reduce$57.01 - $70.46
($65.18)
$ 52.58-19%Reduce -1.38%46,562
ABBVDodge & Cox 2015-06-30 Reduce$57.01 - $70.46
($65.18)
$ 52.58-19%Reduce -2.28%34,255
ABBVNWQ Managers 2015-03-31 Add1.27%$55.48 - $67.63
($60.41)
$ 52.58-13%Add 1815.34%1,839,012
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABBV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GONZALEZ RICHARD AChairman of the Board and CEO 2015-07-29Sell40,021$71.24-26.19view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-07-29Sell24,979$71.09-26.04view
HURWICH THOMAS A.VP, Controller 2015-05-19Sell6,200$66-20.33view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell8,281$64.92-19.01view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell64,232$64.84-18.91view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell102,964$64.67-18.69view
RICHMOND TIMOTHY J.SVP, Human Resources 2015-03-02Sell14,388$60.33-12.85view
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC 2015-03-02Sell25,000$60.3-12.8view
HURWICH THOMAS A.VP, Controller 2015-02-27Sell1,185$60.57-13.19view
SALEKI-GERHARDT AZITASVP, Operations 2015-02-27Sell2,112$60.47-13.05view

Quarterly/Annual Reports about ABBV:

News about ABBV:

Articles On GuruFocus.com
Gilead, Johnson & Johnson or Roche? Feb 11 2016 
Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
Health Care Investor Larry Robbins Lowers Drug Manufacturers, Raises Providers Nov 20 2015 
Merck & Co. Versus AbbVie: Who Is the Winner and Who Is the Loser? Nov 12 2015 
Companies Return 12-Month Record Amount to Shareholders Sep 25 2015 
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle Aug 20 2015 
JNJ – Should It Be In Your Portfolio? Aug 19 2015 
AbbVie: The Riskiest Dividend Aristocrat Aug 18 2015 
First Eagle Investment Buys 19 Stakes in Second Quarter Aug 17 2015 
Green Square Capital's Top Buys in Q2 2015 Aug 13 2015 

More From Other Websites
Incyte Has Bad Data and Worse Timing Feb 11 2016
Relypsa: This Biotech Just Released Stunning Data Feb 10 2016
Abbvie expects to bring endometriosis drug to FDA in 2017 Feb 10 2016
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
Short Sellers Increase Bets in Major Pharma Feb 10 2016
5 Safe, Strong Stocks to Add to Your Portfolio in Uncertain Times Feb 10 2016
AbbVie, Maker of World's No. 1 Drug, Bets on Synthetic Biology Startup Feb 10 2016
AbbVie Announces Positive Top-Line Results From Second Phase 3 Study Investigating Elagolix in... Feb 10 2016
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
20 dividend stocks that Wall Street loves the most Feb 09 2016
The market in a minute: 5 stocks I really like Feb 08 2016
4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now Feb 08 2016
[$$] J&J, AbbVie Shares Drop on Potential Drug Competition Feb 05 2016
[$$] J&J, AbbVie Shares Drop on Potential Drug Competition Feb 05 2016
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK